Dupixenthcp.com

Visit dupixenthcp.com
  • 1.3K

    Daily Visitors

  • 3 months ago

    Last scanned

  • 7 years

    Domain Age

  • No data

    Global Rank

Dupixenthcp.com

Visit dupixenthcp.com

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

DUPIXENT® (dupilumab) HCP Website

DUPIXENT® (dupilumab) is a dual inhibitor of IL-4 and IL-13 signaling and is approved for 5 indications. Serious adverse reactions may occur. Please see Important Safety Information and full Prescribing Information on website.

Dupixenthcp.com thumbnail
Dupixenthcp.com thumbnail

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Amazon.com, Inc., which reserves the following IP addresses for dupixenthcp.com: 3.162.112.31, 3.162.112.51, 3.162.112.70, 3.162.112.98. Moreover, DNS used with this website include ns1.sanofi-synthelabo.com, ns2.sanofi-synthelabo.com, ns3.sanofi-synthelabo.com, ns4.sanofi-synthelabo.com. Subnet identifier ranges from 3.160.0.0 to 3.163.255.255. Classless Inter-Domain Routing (CIDR) is 3.160.0.0/14. ARIN net type is Reallocated.

  • 1.3K

    Daily Visitors

  • 3 months ago

    Last scanned

  • 7 years

    Domain Age

  • No data

    Global Rank

Trustworthy

Network

ADDRESSING DETAILS

Whois

OWNERSHIP

Domain & Keywords

The registrar of dupixenthcp.com is CSC CORPORATE DOMAINS, INC. and the name expires on 2024-10-13. According to open source data, you can reach the owner at domain.names@sanofi.com but please make sure you have a good reason for unsolicited messages. Their country of residence is France, French Republic.

  • atopic dermatitis
  • severe atopic dermatitis
  • dupilumab
  • dupixent
  • moderate atopic dermatitis
  • IL13 inhibitor
  • dupixent my way
  • il4 antagonist
  • dupixent commercial
  • dupixent ad

Websites similar to dupixenthcp.com

Dupixenthcp.com friends